MEI Pharma Inc (MEIP) — Financial Flexibility Index
MEI Pharma Inc (MEIP) has a Financial Flexibility Index of -1.82x as of June 2025. Free cash flow of $-2.46 Million (operating CF $-2.46 Million minus capex $0.00) represents -2% of total liabilities ($1.35 Million). Check MEI Pharma Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
MEI Pharma Inc Financial Flexibility Index (2003–2025)
Historical Financial Flexibility Index trend for MEI Pharma Inc across 23 annual periods. For the full cash flow conversion analysis, see MEI Pharma Inc (MEIP) cash flow conversion.
Annual Financial Flexibility Index for MEI Pharma Inc (2003–2025)
Year-by-year free cash flow to debt coverage for MEI Pharma Inc. Explore MEIP operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -15.39x | $-20.84 Million | $-20.84 Million | $1.35 Million | ▼ -154.9% |
| 2024 | -6.04x | $-50.47 Million | $-50.47 Million | $8.36 Million | ▼ -1007.7% |
| 2023 | -0.55x | $-52.45 Million | $-52.48 Million | $96.19 Million | ▼ -41.7% |
| 2022 | -0.38x | $-48.27 Million | $-48.75 Million | $125.43 Million | ▼ -63.4% |
| 2021 | -0.24x | $-31.26 Million | $-31.96 Million | $132.74 Million | ▼ -188.1% |
| 2020 | 0.27x | $35.15 Million | $34.26 Million | $131.51 Million | ▲ +131.8% |
| 2019 | -0.84x | $-29.21 Million | $-29.42 Million | $34.73 Million | ▼ -116.1% |
| 2018 | -0.39x | $-21.09 Million | $-21.30 Million | $54.20 Million | ▼ -153.5% |
| 2017 | 0.73x | $3.54 Million | $3.49 Million | $4.87 Million | ▲ +122.4% |
| 2016 | -3.24x | $-17.85 Million | $-17.86 Million | $5.51 Million | ▲ +42.7% |
| 2015 | -5.66x | $-28.05 Million | $-28.07 Million | $4.96 Million | ▼ -34.6% |
| 2014 | -4.20x | $-19.40 Million | $-19.45 Million | $4.62 Million | ▲ +29.6% |
| 2013 | -5.97x | $-10.01 Million | $-10.04 Million | $1.68 Million | ▼ -50.7% |
| 2012 | -3.96x | $-7.03 Million | $-7.08 Million | $1.77 Million | ▼ -45.8% |
| 2011 | -2.72x | $-6.45 Million | $-6.50 Million | $2.37 Million | ▲ +52.4% |
| 2010 | -5.72x | $-10.03 Million | $-10.03 Million | $1.75 Million | ▼ -124.3% |
| 2009 | -2.55x | $-10.55 Million | $-10.55 Million | $4.14 Million | ▲ +23.7% |
| 2008 | -3.34x | $-11.50 Million | $-11.50 Million | $3.44 Million | ▲ +22.2% |
| 2007 | -4.29x | $-10.79 Million | $-10.79 Million | $2.51 Million | ▲ +40.5% |
| 2006 | -7.21x | $-9.09 Million | $-9.09 Million | $1.26 Million | ▼ -267.5% |
| 2005 | -1.96x | $-5.58 Million | $-5.58 Million | $2.84 Million | ▲ +53.0% |
| 2004 | -4.18x | $-7.97 Million | $-7.97 Million | $1.91 Million | ▼ -207.2% |
| 2003 | -1.36x | $-1.84 Million | $-1.84 Million | $1.35 Million | — |